Pdf Summary
Keywords
Subcutaneous immunoglobulin therapy
SCIg
intravenous immunoglobulin therapy
IVIg
chronic inflammatory demyelinating polyneuropathy
CIDP
efficacy
venous access requirement
adverse events
patient independence
cidp
Chronic Inflammatory Demyelinating Polyneuropathy


2621 Superior Drive NW
Rochester, MN

P 507.288.0100

F 507.288.1225

aanem@aanem.org

                   

© 2024 American Association of Neuromuscular & Electrodiagnostic Medicine
Powered By